William Benton Jones - Jun 4, 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
SVP, Pharmaceutical Development
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Stock symbol
CRVS
Transactions as of
Jun 4, 2025
Transactions value $
$67,750
Form type
4
Date filed
6/6/2025, 04:26 PM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones William Benton SVP, Pharmaceutical Development C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO /s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D. 2025-06-06 0001664506

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Options Exercise $67.7K +19.4K +12.59% $3.50 173K Jun 4, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRVS Warrant (Right to Buy) Options Exercise -19.4K -100% 0 Jun 4, 2025 Common Stock 19.4K $3.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312 per share.

Remarks:

SVP, Pharmaceutical Development